The authors noted that low croploads during the study period may also have contributed to
reduced effects of treatments on cherry quality characteristics other than size.
Not exact matches
These risks and uncertainties include: Gilead's ability to achieve its anticipated full year 2018 financial results; Gilead's ability to sustain growth in revenues for its antiviral and other programs; the risk that private and public payers may be reluctant to provide, or continue to provide, coverage or reimbursement for new products, including Vosevi, Yescarta, Epclusa, Harvoni, Genvoya, Odefsey, Descovy, Biktarvy and Vemlidy ®; austerity measures in European countries that may increase the amount
of discount required on Gilead's products; an increase in discounts, chargebacks and rebates due to ongoing contracts and future negotiations with commercial and government payers; a larger than anticipated shift in payer mix to more highly discounted payer segments and geographic regions and decreases in
treatment duration; availability
of funding for state AIDS Drug Assistance Programs (ADAPs); continued fluctuations in ADAP purchases driven by federal and state grant cycles which may not mirror patient demand and may cause fluctuations in Gilead's earnings; market share and price erosion caused by the introduction
of generic versions
of Viread and Truvada, an uncertain global macroeconomic environment; and potential amendments to the Affordable Care Act or other government action that could have the
effect of lowering prices or
reducing the number
of insured patients; the possibility
of unfavorable results from clinical trials involving investigational compounds; Gilead's ability to initiate clinical trials in its currently anticipated timeframes; the levels
of inventory held by wholesalers and retailers which may cause fluctuations in Gilead's earnings; Kite's ability to develop and commercialize cell therapies utilizing the zinc finger nuclease technology platform and realize the benefits
of the Sangamo partnership; Gilead's ability to submit new drug applications for new product candidates in the timelines currently anticipated; Gilead's ability to receive regulatory approvals in a timely manner or at all, for new and current products, including Biktarvy; Gilead's ability to successfully commercialize its products, including Biktarvy; the risk that physicians and patients may not see advantages
of these products over other therapies and may therefore be reluctant to prescribe the products; Gilead's ability to successfully develop its hematology / oncology and inflammation / respiratory programs; safety and efficacy data from clinical studies may not warrant further development
of Gilead's product candidates, including GS - 9620 and Yescarta in combination with Pfizer's utomilumab; Gilead's ability to pay dividends or complete its share repurchase program due to changes in its stock price, corporate or other market conditions; fluctuations in the foreign exchange rate
of the U.S. dollar that may cause an unfavorable foreign currency exchange impact on Gilead's future revenues and pre-tax earnings; and other risks identified from time to time in Gilead's reports filed with the U.S. Securities and Exchange Commission (the SEC).
The study focused on a progesterone gel
treatment that was found to be effective in
reducing early births
of singletons but did not have the same
effect with multiples.
Before beginning
treatment, talk to your child's pediatrician about your concerns regarding potential side
effects and how to
reduce your child's risk
of complications.
«The goals
of asthma
treatment are to
reduce the patient's symptoms, help ensure that they can maintain their normal activities, perform well on pulmonary function tests and minimize asthma associated risks such as future asthma attacks and medication side
effects,» said Jennifer McCracken, UTMB assistant professor in the department
of internal medicine, division
of allergy and immunology.
«But, we wanted to examine if there were any
treatments or interventions that could aid to minimize the
effect of sleep loss by
reducing the severity
of pain experienced after surgery.»
«Our study suggests that in patients with heart failure and atrial fibrillation, catheter ablation is an effective alternative
treatment that can help patients avoid or discontinue this drug to
reduce the risk
of these long - term side
effects.»
«The
treatment method involves administering these substances over the course
of a day to
reduce the rewarding
effect.
By targeting different hormones that help the body manage its own insulin levels — and by
reducing side
effects such as weight gain — three drugs recently approved by the FDA avoid most
of the major problems associated with past diabetes
treatments.
Pending further research, the evidence may point to possible
treatments to
reduce the
effects of low blood oxygen on mood and suicidal thoughts.
The recommendations aim to
reduce unnecessary
treatment for prostate cancer and potential long - term side
effects from it, according to the University
of North Carolina Lineberger Comprehensive Cancer Center member who first - authored the report.
«Shortening
treatment regimens and
reducing the required doses may be a promising strategy to
reduce the incidence
of bedaquiline - related adverse
effects and thereby improve multidrug - resistant TB
treatment outcomes,» says Gupta.
While lithium carbonate has been very effective for the
treatment of mania in bipolar disorder, and credited for
reducing suicides in depressive phases
of the disease, patients who take lithium carbonate are often noncompliant because
of adverse
effects, including hand tremor, diarrhea, vomiting, weight gain and decreased thyroid function.
However, all other outcomes failed to show an
effect of baclofen: baclofen did not increase abstinent days or decrease number
of heavy drinking days during
treatment, neither did it
reduce rates
of alcohol craving, anxiety or depression.
The combination
of the two drugs could potentially shorten
treatment time,
reduce the side
effects of bedaquiline and improve patient outcomes for those suffering from TB.
«The advantage
of being able to deliver methotrexate in this targeted way is to be able to gain the benefits from this key
treatment of RA, while
reducing the risk
of adverse
effects that are more frequent at high doses,» concluded Dr Macor.
«New soft material could
reduce complications for women suffering from urinary incontinence: Researchers have developed a novel implantable material which could
reduce the number
of debilitating side -
effects that occur as a result
of using a material that is too rigid for surgical
treatment of incontinence.»
Researchers at the University
of Sheffield have developed a novel implantable material which could
reduce the number
of debilitating side -
effects that occur as a result
of using a material that is too rigid for surgical
treatment of incontinence.
«This is why we're diligently working to employ several strategies that we hope will lead us to reaching our ultimate goal
of developing the best therapy possible — a therapy that can be given to patients as a first line
of defense, greatly
reducing the side
effects of cancer
treatment and leading to a cure.»
According to Dr. Rosamilia, early
treatment not only can
reduce the pain and severity
of the disease, but also can help prevent potential side
effects like eye problems, infection, and a condition called post-herpetic neuralgia, which causes pain, numbness, itching and tingling.
«It's important to understand the mechanisms
of action
of chemotherapy on spermatogenesis to help clinicians make informed decisions on adjusting
treatment,
reducing side
effects, and better advising patients on family planning,» says INRS's Dr. Géraldine Delbès, reproductive toxicology specialist and the author in charge
of this study.
A team
of researchers at the University
of Georgia has developed a non-invasive method
of delivering drugs directly to cancerous tissue using magnetic forces, a form
of treatment that could significantly
reduce the toxic side
effects of chemotherapy.
Statistical modeling
of the results revealed that, on average, patients experienced significantly
reduced scores for the active
treatment, though the size
of the
effect in individual patients varied.
«Our collaboration with scientists at Charles Gerhardt Institute was important to the success
of this two - photon activated technique,» said Tamanoi, «which provides controls over drug delivery to allow local
treatment that dramatically
reduces side
effects.»
Not only does this
reduce the
effect of a chemotherapy
treatment, but it also creates hydrogen fluoride, a gas that can be harmful both to the patients and to the medical equipment.
Researchers trying out new
treatments need to make sure any
effect the
treatment has in
reducing the incidence
of heart disease is statistically significant.
The authors point to studies
of harmful and beneficial
effects of thrombolytic and antiarrhythmic drugs for myocardial infarction, for example: «Not only would systematic reviews... have
reduced waste resulting from unjustified research, they would also have shown how to
reduce morbidity and sometimes mortality, both in patients allocated to relatively less effective or actually harmful
treatments in unnecessary trials, and in patients generally,» the authors write.
Merkx: «By directly linking the measurement
of antibodies to the
treatment of the disease, we may be able to prevent side -
effects and
reduce costs in the future.»
Newer evidence suggests that the shorter course
of treatment does not
reduce the benefits
of therapy; in addition this can
reduce antibiotic - related side
effects, the risk
of Clostridium difficile, a serious diarrheal infection, antibiotic resistance and costs, said Dr. Kalil.
The research, which appears in the journal The Lancet Oncology, should aid efforts to
reduce and better manage the late
effects of cancer
treatment.
«Cancer doesn't sleep: MYC oncogene disrupts clock, metabolism in cancer cells: Findings inform time - dependent
treatment for
reducing side
effects, increasing effectiveness
of cancer medications.»
Possible long - term interventions to
reduce mortality and morbidity after high exposures end include disease screening,
reducing important co-exposures,
treatment and health services resource planning, and increasing public awareness
of arsenic health
effects.
Although fewer activated T cells were generated after a
treatment with 3pRNA, the positive
effect of the leukemia therapy was not
reduced to a measurable degree.
«While there are clearly other factors that can cause these types
of abnormalities, including genetic vulnerabilities, demonstrating that immune activation alone can produce these
effects offers new hope for
treatments that might
reduce their severity, or prevent them altogether, in certain individuals.»
«This research is important because it identifies a way to
reduce some
of what, in medical
treatment, are usually thought
of as THC's unwanted side
effects, while maintaining several important benefits including pain reduction.»
But
treatment to
reduce 5HT2AR did not change other
effects of THC, including pain relief.
The drug — named mepolizumab — can replace traditional, steroid - based
treatments for a specific subset
of patients, resulting in improved outcomes and
reduced side
effects.
Noelle Frey, MD, an assistant professor
of Hematology - Oncology, will present results in 27 adult patients with acute lymphoblastic leukemia (ALL), identifying an optimal dose and infusion regimen that should improve
treatment response while
reducing potential for side
effects.
A new class
of drugs
reduced the risk
of patients contracting a serious and often deadly side
effect of lifesaving bone marrow transplant
treatments, according to a study from researchers at the University
of Michigan Comprehensive Cancer Center.
The adverse
effects of epinephrine appeared to be unaffected by the use
of post-resuscitation medical
treatments, such as techniques to cool the body to
reduce tissue damage or interventions to restore the flow
of blood through blocked arteries.
Although doctors have long incorporated personal information like family history into
treatment plans, personalized medicine holds the promise
of revolutionizing medical care by using knowledge
of molecular biology and genetics that will allow more precise diagnoses, better diagnostic tests, greater predictability
of disease course, more successful therapies by targeting the right
treatments to the right patients, and improved patient safety by selecting drugs and their proper dosage to
reduce adverse side
effects.
«This paves the way for a whole new class
of anti-inflammatory agents, inspired by quebecol, that could compensate for the low efficacy
of certain
treatments while
reducing the risk
of side
effects.»
A move to lengthen limbs internally rather than via an external scaffold could
reduce the
effects of painful
treatments, especially among younger patients
He says that the new nanoparticles accumulate preferentially in tumors, which could drastically
reduce the side
effects of current cancer
treatments that usually kill healthy cells along with the targeted cancer cells.
Other projects include an analysis
of regional variations
of cancer
treatment in Texas, a study
of the
effect of smoking bans on hospitalization rates, and a study
of whether shared savings programs for physicians can
reduce overall patient health care expenditures.
«This research shows great promise to
reduce adverse
effects for people undergoing breast cancer
treatment,» said Timothy M. Block, PhD, president
of the Baruch S. Blumberg Institute, which manages PCARMRC.
July 13, 2016 Simple procedure could improve
treatment for common eye disease: Rejuvenating the cornea could
reduce the need for cornea transplants A new, minimally invasive procedure appears to be effective for many patients with Fuchs endothelial dystrophy (FED), a common eye disease, without the potential side
effects and cost
of the current standard
of care, a cornea transplant.
Restricting the movement
of the drug also
reduces potentially harmful secondary
effects on other parts
of the body — for instance, the hair loss that can result from toxic cancer
treatments, or the loss
of so - called good bacteria due to antibiotic use.
J147
treatment also resulted in a significant
effect on Aβ metabolism,
reducing levels
of soluble Aβ without an
effect on plaque density or size (Figure 2).
By engineering the devices to release their payloads only once they reach the site
of the tumor, the researchers hope to
reduce dosages and also limit the side
effects of conventional
treatments.